CORESTEMCHEMON Inc. (KOSDAQ:166480)

CORESTEMCHEMON Revenue

CORESTEMCHEMON had revenue of 5.40B KRW in the quarter ending June 30, 2026, a decrease of -1.73%. This brings the company's total for the last twelve months to 18.29B, down -26.34% year-over-year. In the year 2025, CORESTEMCHEMON had annual revenue of 20.16B, down -29.91%. That makes CORESTEMCHEMON the 35,897th largest company in the world by revenue and 2,294th in South Korea.

• Revenue (ttm): 18.29B
• Revenue Growth: -26.34%
• P/S Ratio: 3.88
• Revenue / Employee: 63.29M
• Employees: 289
• Market Cap: 70.40B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Non-Clinical Trial Agency Division 27.64B 94.7%
• Cell Therapy Pharmaceutical Sector 1.56B 5.3%

By Geography

Chart

• South Korea 29.18B 99.9%
• Other 26.57M 0.1%

Fiscal year ended Dec 31, 2024 See the full CORESTEMCHEMON breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	20.16B	-8.60B	-29.91%
Dec 31, 2024	28.76B	-4.89B	-14.54%
Dec 31, 2023	33.66B	-12.22B	-26.64%
Dec 31, 2022	45.88B	15.64B	51.71%
Dec 31, 2021	30.24B	3.88B	14.73%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error